4//SEC Filing
Galligan Andrew H 4
Accession 0001567619-20-000740
CIK 0001444380other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 12:00 PM ET
Size
8.2 KB
Accession
0001567619-20-000740
Insider Transaction Report
Form 4
NEVRO CORPNVRO
Galligan Andrew H
VP of Finance , CFO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-01-06−2,782→ 17,718 totalExercise: $63.23Exp: 2025-11-30→ Common Stock (2,782 underlying) - Exercise/Conversion
Common Stock
2020-01-06$63.23/sh+2,782$175,906→ 56,272 total - Sale
Common Stock
2020-01-06$120.00/sh−2,782$333,840→ 53,490 total
Footnotes (3)
- [F1]Includes 16,773 restricted stock units.
- [F2]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F3]Fully vested.
Documents
Issuer
NEVRO CORP
CIK 0001444380
Entity typeother
Related Parties
1- filerCIK 0001417976
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 12:00 PM ET
- Size
- 8.2 KB